Forskning ved Københavns Universitet - Københavns Universitet


Plasma chromograninx: Plasma chromogranin A is a marker of death in elderly patients presenting with symptoms of heart failure

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt


  • ec-03-047

    Forlagets udgivne version, 246 KB, PDF-dokument

Cardiovascular risk assessment remains difficult in elderly patients. We examined whether chromogranin A (CgA) measurement in plasma may be valuable in assessing risk of death in elderly patients with symptoms of heart failure in a primary care setting. A total of 470 patients (mean age 73 years) were followed for 10 years. For CgA plasma measurement, we used a two-step method including a screening test and a confirmative test with plasma pre-treatment with trypsin. Cox multivariable proportional regression and receiver-operating curve (ROC) analyses were used to assess mortality risk. Assessment of cardiovascular mortality during the first 3 years of observation showed that CgA measurement contained useful information with a hazard ratio (HR) of 5.4 (95% CI 1.7-16.4) (CgA confirm). In a multivariate setting, the corresponding HR was 5.9 (95% CI 1.8-19.1). WHEN ADDING N-TERMINAL PROBNP (NT-PROBNP) TO THE MODEL, CGA CONFIRM STILL POSSESSED PROGNOSTIC INFORMATION (HR: 6.1; 95% CI 1.8-20.7). The result for predicting all-cause mortality displayed the same pattern. ROC analyses in comparison to NT-proBNP to identify patients on top of clinical variables at risk of cardiovascular death within 5 years of follow-up showed significant additive value of CgA confirm measurements compared with NT-proBNP and clinical variables. CgA measurement in the plasma of elderly patients with symptoms of heart failure can identify those at increased risk of short- and long-term mortality.

TidsskriftEndocrine Connections
Udgave nummer1
Sider (fra-til)47-56
Antal sider10
StatusUdgivet - 2014

Antal downloads er baseret på statistik fra Google Scholar og

Ingen data tilgængelig

ID: 138816992